Malaysian-Made ProDetect(R) Rapid Test-Kit Scores 100% Accuracy in International Assessment
GEORGE TOWN, Malaysia, March 2, 2022 /PRNewswire/ -- As the Omicron variant takes hold in Malaysia, the availability of high accuracy Antigen Test Kits is increasingly vital in the drive to identify infection early on and prevent further spread in the community. The ProDetect® COVID-19 Antigen Rapid Test, manufactured in Malaysia by Medical Innovation Ventures Sdn Bhd (Mediven®), recently...
ImmVira’s breakthrough intravenous oncolytic virus product MVR-T3011 IV completed first dosing in Phase I clinical trial in China
SHENZHEN, China, March 2, 2022 /PRNewswire/ -- Following its robust safety data in the U.S. Phase I clinical study, ImmVira announced that its global first intravenous administered oncolytic herpes simplex virus ("oHSV") product MVR-T3011 IV has completed first dosing on March 1, 2022 and initiated Phase I clinical trial in a series of well-known domestic clinical study centers in...
Antengene Announces XPOVIO® Regulatory Approval in Singapore for the Treatment of Relapsed and/or Refractory Multiple Myeloma and Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Three Indications
SHANGHAI and HONG KONG, March 2, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for cancer and other life-threatening diseases, announced today that XPOVIO®(selinexor) has been granted approval from the Health Sciences Authority (HSA) in Singapore...
Amrita University launch wearable device for home monitoring of glucose and BP
- Patients can use the wearable, non-invasive device to measure six body parameters including blood glucose, blood pressure, heart rate, blood oxygen, respiratory rate and 6-lead ECG, from the comfort of their home - The device, connected to the smart phone, can serve as a micro-bedside monitor in rural clinics KOCHI, India, March 2, 2022 /PRNewswire/ -- Amrita University has...
OrthoLite Introduces Cirql Midsole Foam Solution to Revolutionize and Drive Sustainability in the Footwear Industry
AMHERST, Mass., March 2, 2022 /PRNewswire/ -- OrthoLite, the 25-year industry leader of branded, high performance, comfort footwear solutions, today unveils its first-ever midsole foam innovation to elevate sustainability in the footwear industry: Cirql. OrthoLite Cirql is the critical solution needed to achieve true circularity within the footwear industry, and is the world's first...
The Sigourney Trust Issues Call For Entries Of Psychoanalytic Work Eligible To Win The Sigourney Award-2022
Applications For The Sigourney Award-2022 Accepted March 1 Through July 31 SEATTLE, March 1, 2022 /PRNewswire/ -- Each year The Sigourney Trust honors up to four individuals, groups or organizations with an independent prize, The Sigourney Award. This prestigious international award honors recent outstanding achievements in psychoanalytic work. Winning work earns The Sigourney...
Cambrex Expands Biopharmaceutical Services Business
EAST RUTHERFORD, N.J., March 1, 2022 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, today announced it is significantly expanding its existing biopharmaceutical testing services business. The expansion includes 11 additional cGMP laboratories at Cambrex's Durham,...
Vocera, now part of Stryker, introduces latest evolution in hands-free communication to help protect and connect healthcare workers
New Minibadge expands intuitive mobile solutions for care team collaboration and safety KALAMAZOO, Michigan, USA, March 1, 2022 /PRNewswire/ -- Vocera, now part of Stryker, a global leading medical technology company, introduced the new Minibadge, a wearable, voice-driven device that enables mobile workers to communicate completely hands-free. The launch of this small,...
Kintor Pharma Announces First Patient Dosing in Phase II Clinical Trial of KX-826 for Treatment of Androgenic Alopecia Patients in the US
SUZHOU, China, March 1, 2022 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma," HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, today announced the first patient dosing in its phase II clinical trial of KX-826 ("pyrilutamide") in the US for the treatment of male androgenetic alopecia (AGA) patients on February 28, 2022. AGA is the...
Rare Disease Day | With iCare, Love is Not Rare, MediTrust Health – iCare Clover Gives Care and Protection to Rare Disease Patients
SHANGHAI, March 1, 2022 /PRNewswire/ -- "When Zixu was about 10 months old, he already seemed different from other children. He has curved fingers, a gradually bulging belly, and his intelligence also grows slowly," Zixu's mother calmly recounted the process of taking her child to seek medical treatment. "Out of concerns and worries, we took our kid to see...
